Authors:
Knight, GJ
Palomaki, GE
Neveux, LM
Haddow, JE
Lambert-Messerlian, GM
Citation: Gj. Knight et al., Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screening, J MED SCREE, 8(1), 2001, pp. 2-7
Citation: Je. Haddow, Should we abandon the concept of giving patients "positive" and "negative"screening results? No: We should do better at explaining results, WEST J MED, 174(6), 2001, pp. 373-373
Authors:
Allan, WC
Haddow, JE
Palomaki, GE
Williams, JR
Mitchell, ML
Hermos, RJ
Faix, JD
Klein, RZ
Citation: Wc. Allan et al., Maternal thyroid deficiency and pregnancy complications: implications for population screening, J MED SCREE, 7(3), 2000, pp. 127-130
Citation: Je. Haddow et al., First trimester biochemical screening for Down syndrome: free beta hCG versus intact hCG - Response to Hallahan et al., PRENAT DIAG, 20(10), 2000, pp. 790-791
Authors:
Mitchell, ML
Hermos, RJ
Larson, CA
Palomaki, GE
Haddow, JE
Citation: Ml. Mitchell et al., Prevalence of GAD autoantibodies in women with gestational diabetes - A retrospective analysis, DIABET CARE, 23(11), 2000, pp. 1705-1706
Authors:
Haddow, JE
Bradley, LA
Palomaki, GE
Doherty, RA
Bernhardt, BA
Brock, DJH
Cheuvront, B
Cunningham, GC
Donnenfeld, AE
Erickson, JL
Erlick, HA
Ferrie, RM
FitzSimmons, SC
Greene, MF
Grody, WW
Haddow, PK
Harris, H
Holmes, LB
Howell, RR
Katz, M
Klinger, KW
Kloza, EM
LeFevre, ML
Little, S
Loeben, G
McGovern, M
Pyeritz, RE
Rowley, PT
Saiki, RK
Short, MP
Tabone, J
Wald, NJ
Wilker, NL
Witt, DR
Citation: Je. Haddow et al., Issues in implementing prenatal screening for cystic fibrosis: Results of a working conference (vol 1, pg 129, 1999), GENET MED, 1(5), 1999, pp. 193-193
Authors:
Haddow, JE
Bradley, LA
Palomaki, GE
Doherty, RA
Bernhardt, BA
Brock, DJH
Cheuvront, B
Cunningham, GC
Donnenfeld, AE
Erickson, JL
Erlich, HA
Ferrie, RM
FitzSimmons, SC
Greene, MF
Grody, WW
Haddow, PK
Harris, H
Holmes, LB
Howell, RR
Katz, M
Klinger, KW
Kloza, EM
LeFevre, ML
Little, S
Loeben, G
McGovern, M
Pyeritz, RE
Rowley, PT
Saiki, RK
Short, MP
Tabone, J
Wald, NJ
Wilker, NL
Witt, DR
Citation: Je. Haddow et al., Issues in implementing prenatal screening for cystic fibrosis: Results of a working conference, GENET MED, 1(4), 1999, pp. 129-135
Authors:
Haddow, JE
Bradley, LA
Palomaki, GE
Doherty, RA
Citation: Je. Haddow et al., Issues in implementing prenatal screening for cystic fibrosis: results of a working conference, J MED SCREE, 6(2), 1999, pp. 60-66
Citation: Je. Haddow et La. Bradley, Hereditary haemochromatosis: to screen or not - Conditions for screening are not yet fulfilled, BR MED J, 319(7209), 1999, pp. 531-532
Authors:
Hayde, M
Bernaschek, G
Stevenson, DK
Knight, GJ
Haddow, JE
Widness, JA
Citation: M. Hayde et al., Antepartum fetal and maternal carboxyhemoglobin and cotinine levels among cigarette smokers, ACT PAEDIAT, 88(3), 1999, pp. 327-331
Authors:
Bradley, LA
Palomaki, GE
Knight, GJ
Haddow, JE
Opitz, JM
Irons, M
Kelley, RI
Tint, GS
Citation: La. Bradley et al., Levels of unconjugated estriol and other maternal serum markers in pregnancies with Smith-Lemli-Opitz (RSH) syndrome fetuses, AM J MED G, 82(4), 1999, pp. 355-358
Authors:
Haddow, JE
Palomaki, GE
Allan, WC
Williams, JR
Knight, GJ
Gagnon, J
O'Heir, CE
Mitchell, ML
Hermos, RJ
Waisbren, SE
Faix, JD
Klein, RZ
Citation: Je. Haddow et al., Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child, N ENG J MED, 341(8), 1999, pp. 549-555
Citation: Je. Haddow et al., Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child - Reply, N ENG J MED, 341(26), 1999, pp. 2017-2017